Staff, Author at Green Market Report

StaffStaffNovember 13, 2018
img_mjf-2.jpg

12min170

New Name Reflects Potential Accelerated Growth Opportunities and
Expanded Acquisition Capabilities of the Combined Organization

New York, NY – November 13, 2018 /AxisWire/ MTech Acquisition Corp. (NASDAQ: MTEC) (“MTech”), the first US-listed Special Purpose Acquisition Company focused on acquiring a business ancillary to the cannabis industry, and MJ Freeway LLC (“MJ Freeway”), a leading seed-to-sale technology provider and developer of the cannabis industry’s first enterprise resource planning platform, today announced “Akerna” as the name of the Nasdaq-listed public company following the consummation of the proposed merger of MTech and MJ Freeway.  MTech and MJ Freeway also announced that they will be attending the largest cannabis conference and expo in the world, The Marijuana Business Conference and Exposition (“MJBizCon”), taking place from November 14-16, 2018, at the Las Vegas Convention Center in Las Vegas, Nevada.  

The companies’ presence at the conference includes two booths:

  • Booth # 1849 will showcase the MJ Platform® technology with four interactive experiences highlighting how seed-to-sale data can enable better business performance
  • Booth # 2019 will feature Akerna, the company that will be created by the proposed merger of MTech and MJ Freeway.

Scott Sozio, Chief Executive Officer of MTech says, “Today’s announcement of Akerna marks a key milestone in the merger process. The name Akerna with “kern” at its center has dual meanings that are significant, both as the core of a computer’s operating system and its relationship to agriculture and growth. This new name reflects the full scope of MTech and MJ Freeway’s goals of providing the technology infrastructure for the cannabis industry while pursuing an aggressive growth strategy of accretive acquisition opportunities.”

Jessica Billingsley, CEO & Co-Founder of MJ Freeway, commented, “MJBizCon Vegas is an event MJ Freeway’s participated in for many years, and we are excited Akerna is now a part. When we started the company, our core focus was on providing compliance and technology solutions to the new cannabis market. With this proposed merger, we believe we will have the capital resources to expand and position ourselves as the dominant market leader in the cannabis SaaS space through a combination of continued organic growth and strategic acquisitions.”

Leadership from both MTech and MJ Freeway will be onsite for investor and press meetings.

As previously announced, MJ Freeway has entered into definitive agreements for a proposed merger with MTech.

About MJ Freeway

Founded in 2010, MJ Freeway is a leading cannabis technology company that creates and sells software, consulting and data solutions for cannabis businesses and government agencies, including cultivation management, point of sale, patient management, inventory tracking systems, and regulatory compliance reporting and monitoring.  MJ Freeway serves domestic clients in 29 states and the District of Columbia, as well as international clients in Australia, Canada, Chile, Colombia, Denmark, New Zealand, South Africa, Spain, Switzerland and Uruguay. Its regulatory software platform to state government regulatory agencies, Leaf Data Systems®, and seed-to-sale tracking software platform to commercial private businesses, MJ Platform®, have processed more than $13 billion in medicinal and recreational cannabis sales to date.

About MTech Acquisition Corp.

MTech Acquisition Corp. is a blank check company formed in September 2017 for the purpose of acquiring, through a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, recapitalization, exchangeable share transaction or other similar business transaction, one or more businesses or assets. MTech’s efforts to identify a prospective target business will not be limited to a particular industry or geographic region, although it intends to focus its search on companies ancillary to the cannabis industry, with a particular sector focus that includes compliance, business intelligence, brand development and media. MTech is led by Chairman Steven Van Dyke and Chief Executive Officer Scott Sozio.

Forward Looking Statements

Certain statements made in this release are “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside MJ Freeway’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. Important factors, among others, that may affect actual results or outcomes include: the inability to obtain MTech stockholder approval of the business combination with MJ Freeway; the inability to complete the transaction contemplated by the merger agreement governing such business combination because of failure of closing conditions or other reasons; the inability to recognize the anticipated benefits of the proposed business combination, which may be affected by, among other things, the amount of cash available following any redemptions by MTech stockholders; the ability of the new public company formed for the proposed MJ Freeway-MTech business combination (“Pubco”) to meet the listing standards of The Nasdaq Stock Market following the consummation of the transactions contemplated by the merger agreement; costs related to the proposed business combination; MJ Freeway’s ability to manage growth; the reaction of MJ Freeway’s customers and suppliers to the business combination; Pubco’s ability to identify and integrate other future acquisitions; rising costs adversely affecting MJ Freeway’s profitability; adverse changes to the legal environment for the cannabis industry; and general economic and market conditions impacting demand for MJ Freeway’s products and services.  See the risk factors that have been disclosed in the registration statement on Form S-4 that was filed with the U.S. Securities and Exchange Commission on November 6, 2018 for additional risks associated with the business combination. None of MTech, Pubco or MJ Freeway undertakes any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Additional Information

For additional information on the proposed transaction, see MTech’s Current Report on Form 8-K, which was filed with the SEC on October 11, 2018.

Investors and security holders of MTech are advised to read the draft of the registration statement, the preliminary proxy statement and amendments thereto, and, when available, the prospectus and the definitive proxy statement in connection with MTech’s solicitation of proxies for its special meeting of stockholders to be held to approve the proposed transaction because the proxy statement/prospectus will contain important information about the proposed transaction and the parties to the proposed transaction. The definitive proxy statement/prospectus will be mailed to stockholders of MTech as of a record date to be established for voting on the proposed transaction. Stockholders will also be able to obtain copies of the registration statement and proxy statement/prospectus, without charge, once available, at the SEC’s website at www.sec.gov or by directing a request to: MTech Acquisition Corp, c/o MTech Sponsor LLC, 10124 Foxhurst Court, Orlando, Florida 32836.

  Participants in the Solicitation

 

MTech, Pubco, MTech’s sponsor, and their respective directors, executive officers, other members of management, and employees, under SEC rules, may be deemed to be participants in the solicitation of proxies of MTech’s stockholders in connection with the proposed transaction.  Investors and security holders may obtain more detailed information regarding the names and interests in the proposed transaction of MTech’s directors and officers in MTech’s filings with the SEC, including MTech’s final prospectus for its initial public offering dated as of January 29, 2018 and that was filed with the SEC on January 30, 2018, and MTech’s Quarterly Reports on Form 10-Q, which were filed with the SEC on May 15, 2018 and August 8, 2018, and such information is also in the Registration Statement on Form S-4 filed with the SEC on November 6, 2018 which includes the proxy statement/prospectus of MTech for the proposed transaction.

No Offer or Solicitation

This communication shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which the offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

 

Media Contact:

Jon Goldberg
KCSA Strategic Communications
Tel. 212.896.1282
Email: jgoldberg@kcsa.com

 


StaffStaffNovember 8, 2018
img_tcc.jpg

7min340

Melbourne’s The Cannabis Company have just released the world’s first ever gin distilled using cannabis terpenes

Melbourne – November 8, 2019 /AxisWire/ “It took quite a few goes to get to a good product,” explains Chief Marketing Officer Cormac Sheehan in an interview with SBS. “As we started adding in botanicals, we began to uncover a gin which was great, but not quite award-winning. That wasn’t good enough – from day one we didn’t want novelty gin. It had to stand on its own two feet as a gin, regardless of the cannabis element. If you never knew it had anything to do with hemp, you still had to be able to enjoy it as a gin. The real breakthrough came when we started adding terpenes to the distillation process.”

 

Terpenes

The innovative new spirit is named “The Myrcene Hemp Gin” in reference to the most abundant terpene found in cannabis, terpenes being the primary constituents of the essential oils in many types of medicinal plants and flowers and can be considered the “essence” of a plant.

Terpenes work with other cannabinoids such as CBD and THC, creating a union of compounds that achieve better results as a group than they would in isolation – an outcome known as “the entourage effect”. Used in high concentrations such as this, terpenes are an increasingly sought-after commodity due to their therapeutic value in dietary health and wellness supplements. When cannabis is utilised for its health-giving properties, it works best as a whole plant therapy featuring more than just isolated cannabinoids.

A Scientific Approach

The Cannabis Company differ from their peers in the burgeoning hemp market due to the work of their visionary CEO Dr. David Stapleton. A Senior Researcher at The University of Melbourne with a Ph.D. in Biochemistry and Molecular Biology, Dr. Stapleton has worked all over the world from Denmark to Canada and published over 100 scientific papers. Forming the Cannabis Company in 2017 together with co-owners Cormac Sheehan and Richard Jameson, the team were committed to taking a scientific approach to “the Tree of Life”, as they refer to the plant for its exceptional qualities in relation to health, sustainability and recreation.

“We’ve got nothing against hippies” explains Sheehan, “but the public image of the cannabis plant is still stuck in the ‘60s. It’s unfortunate, as this plant has a million applications as a food, a medicine, a textile, even as a sustainable fire-resistant building material. Yet it still suffers from considerable stigma, the result being that millions of Aussies are missing out on how it can benefit their lives.”

Myrcene

With an initial release of plant-based vegan hemp products for both the human and pet markets, experiments soon began with the distillation of spirits. Select elements from the hurd, bast and seed of the cannabis plant were used to produce the moulin and brou in spirit’s distillation, giving it a considerable hemp content and earthy woodland character. However, at this stage the spirit was still “just a gin” in terms of taste. Further research was carried out and a variety of terpenes were isolated and examined; extensive testing resulted in myrcene being selected as the backbone of the gin.

Also found in hops, bay leaves and mangoes, Myrcene is known to compose up to 50% of the total terpene content found in individual strains of cannabis, with Myrcene strains reputed to produce joyful and euphoric effects alongside an overall feeling of relaxation. Myrcene is perhaps the most highly-valued terpene due to its ability to ease symptoms of chronic pain and inflammation.

Old World Tradition Meets New World Ingenuity

The breakthrough innovation came about after long hours spent delving into the history books. This uncovered some interesting commonalities between terpenes and spirits, strongly influenced by an early 17th century gin-making practice. Whereas these early pioneers used primitive pot stills and added terpenes to mask the flavour of crudely-produced spirits, The Cannabis Company use column stills to craft a lighter and more refined gin, adding myrcene for its joyful sense of euphoria alongside its relaxation-inducing qualities.

While the history of gin spans the globe, a final fascinating piece of the puzzle brings it all back home. Australia’s dark colonial past meant that quinine (the primary constituent of tonic water) was an essential medicine in former times. With 10% of hospital admissions in Darwin being due to malaria by 1899, quinine was widely employed as the only effective anti-malarial compound available. A common practice in tropical British colonies was to soften quinine’s bitter flavour by adding gin. Australia today has thankfully outgrown many of its more negative colonial echoes, but it still retains one old habit which has now gone global: taking the edge off the mozzies with a cool gin & tonic.

Small-batch crafted in Healesville Victoria, the initial release is limited to just 300 bottles.

For more information go to https://cannabiscompany.com.au/products/the-myrcene-hemp-gin

For media inquiries contact:
Cormac Sheehan
Chief Marketing Officer
The Cannabis Company
Email: c.sheehan@cannabiscompany.com.au
Phone: 0416 712 812


StaffStaffNovember 8, 2018
img_hightide.jpg

7min550

Malibu, CA -November 8, 2018 /AxisWire/ Malibu’s residents are flying high from the news of the passing of Measure G which allows adult use cannabis and delivery in the city of Malibu.  The Measure passed with a landslide of 69% of Malibu’s residents voting in favor of the measure.  

“Malibu is the first city in California since Prop. 64, to have a ban overthrown by its residents.  It feels amazing to be making history”! Says Malibu resident and Actress-Activist and CEO of the world famous 99 High Tide dispensary in Malibu, California.  Yvonne DeLaRosa Green, serendipitously, this time last year, also made LA cannabis history by being the first person to receive an LA County Business license for cannabis.

Ms. DeLaRosa Green along with her husband and COO of the 99 High Tide Malibu Dispensary, Sam Huntington Boyer IV, who incidentally is a direct descendant of Sam Huntington, one of the signers of the Declaration of Independence (notably created on Hemp Paper), co-authored Malibu’s Measure G.  

“Malibu is our hometown and we were determined to take Malibu back to its proper legacy and that is one of always having embraced cannabis. From surf culture to Hollywood films and all genres of music, cannabis has always been a part of Malibu culture”.  

99 High Tide Malibu’s General Manager, Vanessa Rodriguez said  “The will of the people has finally been honored and we are so excited to have been a part of this process”.  

The sentiments were echoed by resident and Measure G campaign coordinator, Liz Dean.  “I could not be more proud. Cannabis saved my mother’s life.  Now more people like my mom can be healed.  This is a great day”.  

With the passing of Proposition 64 in 2016 which legalized Cannabis for adult use, a little known fact was that cities were given the right to ban any and all cannabis activity.  Much to the shock and chagrin of Malibu residents a few of the city council members chose not to honor the fact that Malibu had one of the largest amounts of votes for Prop. 64, over 70%.  

 “When seniors and disabled patients began to come into the shop in wheelchairs and one mother came in crying because her son was having an epileptic seizure in the car and she could no longer get delivery, it was then that we realized we had to do something”, says DeLaRosa Green. 

“So we took it to the people of Malibu”.  says Boyer.  In a record breaking amount of time with a record breaking amount of more signatures than required, DeLaRosa Green, Boyer and the Malibu community came together for a true grassroots movement, qualifying their initiative for the November 2018 ballot.  

DeLaRosa Green says she, Boyer and her team of mermen and mermaids (99 High Tide’s heads of security and cannabis consultants) will always stand up for what is right and that the fight for cannabis is still ongoing.  “There are still many cities that have banned cannabis in their communities and that feels very wrong.  We have seen so many people healed with cannabis.  To deny anyone the right to heal themselves naturally is against all that is right.  says DeLaRosa Green

“We have created a successful road map for cities to follow in their pursuit of adult use cannabis in their cities and we hope all cannabis bans will cease to exist.”.  Says Boyer. 

Another part of Measure G was the 2.5% tax, which is one of the lowest city taxes on adult use cannabis in all of California.  One of the wealthiest cities in the world, will now be the least expensive to purchase adult use cannabis.  Yet another reason to love Malibu.  

For more information on Measure G or the 99 High Tide Collective

Contact:  Yvonne DeLaRosa Green

310.963.1969. 


StaffStaffNovember 6, 2018
daily_hit004-1280x533.png

3min860

It’s time for your Daily Hit of cannabis financial news for November 6, 2018.

On The Site

Millions of Americans will head to the polls to cast their vote in the U.S. 2018 Midterm Elections. As is often said, many are calling this one of the most important elections in a generation; and for the cannabis industry, it might actually be true.

On the ballot in four U.S. states are measures that are measures that would legalize either adult-use or medical cannabis in some shape or fashion. Those four key states are Michigan, North Dakota, Utah, and Missouri. Here’s a quick look at each ballot initiative and their odds of successfully passing.

In Other News

Insys Therapeutics

Insys Therapeutics (INSY)  reported its earnings for the quarter ending September 2018 after the close of the market on Monday. The biotech firm delivered a quarterly loss of $0.37 per share missing the Zacks Consensus Estimate of a loss of $0.20. A year ago the company reported a loss of $0.21 for the same time period.

The company also delivered revenues of $18.35 million, which also fell short of Zack’s estimate by 18%. Last year, Insys reported revenues of $30.67 million for the same quarter. The company also said that it was reviewing its portfolio of opioid assets including Subsys.

“With a number of clinical and regulatory milestones to achieve over the next few quarters, including the completion of the CBD and epinephrine studies and filing the naloxone NDA, we believe this is the appropriate time to evaluate strategic alternatives for our opioid-related assets,” the company said.

KushCo Holdings

KushCo Holdings, Inc. (OTCQB: KSHB)  formed a new Advisory Board to provide strategic advice and expertise to help accelerate growth, manage risk and enhance operational performance. Its first three appointments are Matthew Morgan, an entrepreneur and business consultant with leadership experience in the cannabis and other CPG industries, Eric Smith, an industry veteran in the Liquefied Petroleum Gas industry, and Ali Jahangiri, a digital publishing pioneer who has established and grown several businesses.


StaffStaffNovember 6, 2018
Screen-Shot-2018-11-06-at-5.59.42-AM.png

5min940

House of Saka to be the quintessence of infused luxury by and for women

Napa Valley, California – November 6, 2018 /AxisWire/ House of Saka, Inc. announces the launch of Saka Wines, the world’s first luxury line of cannabis-infused, alcohol-removed wines from Napa Valley. Saka’s Sparkling Brut Rosé and still Rosé wines are blended with a proprietary formulation of tasteless, odorless water-soluble ratio of THC and CBD derived from organic craft cannabis and powered by cutting edge technology. The first infused beverages of their kind, Saka promises to deliver a truly elevated infused experience.  

Saka Wines are the first release from House of Saka, Inc, a company formed by and for women dedicated to the development of luxury-infused relaxation, beauty & wellness products for sophisticated consumers around the world.  

Based in in Napa Valley, the world’s foremost wine growing region, Saka Wines are Pinot Noir-based and sourced from hand-selected vineyards across the valleys coolest and most prolific sub-AVAs. The wines are traditionally fermented in stainless steel, after which the alcohol is gently removed and then infused with SAKA’s proprietary, patent-pending formulated ratio of THC:CBD.

“After almost 30 years of spearheading innovation in the adult beverage space and working with some of the most recognized wine and spirit brands  in the world, I am confident that cannabis-infused products are the future,” express Saka Wines CEO, Tracey Mason. “What the sector lacks are true luxury products targeted to a sophisticated female consumer.  That’s what we’re singularly-focused on delivering: Infused Luxury by and for Women

“The concept for this brand began 5 years ago and it was all about the right team and timing to launch the best tasting cannabis infused wine in existence. With regulations and infrastructure mature enough to bring the brand to life, I knew it was the perfect time,” said House of Saka & Saka Wines Founder, Cynthia Salarizadeh. “Wine has been infused with cannabis for as long as we can find in sacred texts throughout history. It is an appropriate time for a luxury line of products at the highest quality to enter the market.”

Saka Wines, a subsidiary of The House of Saka infused-luxury beauty wellness products set to enter the market in mid 2019, are slated to reach shelves in Q1 of 2019 and will be available in over 600 stores throughout California and Nevada before expanding nationwide and globally. In addition, a highly-limited ultra-exclusive, alcohol-removed cannabis and CBD infused sparkling wine sourced from the Champagne region of France will be available for pre-orders by spring of 2019

Saka’s proprietary, patent-pending scientific formulations as well as all manufacturing, production and distribution plans will remain confidential. All Saka products are for consumers that are at least 21 years old and are fully compliant with regulations in the states in which it will be available.

About Saka Wines:

Headquartered in Napa Valley, CA, Saka Wines are a subsidiary of the luxury-infused beauty and wellness company ‘House of Saka.’  Considered the world’s first luxury line of alcohol-free, cannabis-infused wines, Saka Wines are infused with a proprietary, patent-pending water-soluble formulation powered by trade secret science by the world’s top cannabinoid research company. House of Saka boasts an all-female team guided by an all-female advisory board with over 100 collective years experience in wine, cannabis and luxury branding. For more information, please visit houseofsaka.com or follow us on social media @InfusedSaka.

 

Media Contact:

Cynthia Salarizadeh

House of Saka

Cynthia@SalarMediaGroup.com

 


StaffStaffNovember 5, 2018
daily_hit004-1280x533.png

3min1490

It’s time for your Daily Hit of cannabis financial news for November 5, 2018.

On The Site

Aurora Cannabis

Aurora Cannabis Inc.  (ACB) has made a $20 million investment in the emerging adult-use cannabis company Choom Holdings Inc. (OTCQB: CHOOF). The conversion price is approximately C$1.25 per share. Aurora has also secured the ability to purchase up to 40% of the company at a price of C$2.75 a share.

In addition to the investment in the company’s cannabis products, Choom is also developing a chain of retail stores with a “strong focus on elevated customer experiences.” In a company statement, Choom said it has the rights to open 45 retail stores across Western Canada, granted these stores are subject to local approvals. So far, 45 applications have been submitted, along with 27 development permits and 18 building permits received from various towns.

Golden Leaf Holdings

Golden Leaf Holdings Ltd.  (OTCQB: GLDFF) announced financial results for the fiscal third quarter ending September 30, 2018. The company delivered quarterly revenues of US$5.1 million for Q3 2018, compared to US$3.1 million for Q3 2017. The net loss for Q3 2018 was $5.5 million or $0.01 per share loss, compared with a net loss of $3.2 million or $0.01 per share loss, for Q3 2017. Net loss for Q3 2018 increased primarily attributed to the effect of the changes in fair value of non-cash assets and debt, specifically, biological assets and warrant liability.

Golden Leaf also announced it was merging with Terra Tech as the CEO William Simpson will step down as CEO to become President and Derek Peterson will take over as CEO.

In Other News

Green Growth

Green Growth Brands closed on an additional private placement investment of approximately C$30.5 million with a strategic partner, at a post-transaction consolidation price of C$2.00 per share. According to the statement, the subscriber further intends to exercise approximately C$24.5 million of common share purchase warrants of GGB issued under the private placement, with each exercisable on the same consolidation price of C$2.00 per share. The subscriber will be required to make payment of the C$24.5 million exercise price within 30 days. Assuming exercise of and full payment for the warrants, the total funds raised by GGB following the announcement of the Transaction will exceed C$140 million.


StaffStaffNovember 5, 2018
img_nis.jpg

6min460

Denver, Colorado, November 5, 2018 /AxisWire/ Nexien BioPharma Inc. (OTC QB: NXEN)  (“Nexien” or the “Company”) announced that it was initiating an investigation into the use of cannabinoid-based formulations for the treatment of patients suffering from Myotonic Dystrophy (DM) and Myotonia.

Munich-based Dr. Benedikt Schoser, who joined Nexien as a scientific advisor in July, and myotonic dystrophy patient organizations, recently shared two questionnaires. One was in Germany and the other in the United States with both DM type 1 and DM type 2 patients. The purpose of the questionnaires was to determine patient experience with cannabinoids and if cannabinoids were used, to identify whether symptom relief occurred. Results of both questionnaires suggest further exploration is warranted. The detailed results are under review presently at a scientific medical journal.

Additional clinical observations will be summarized soon by Dr. Schoser. The patient group consists of patients suffering from non-dystrophic myotonia, and both types of myotonic dystrophies.  If the summary indicates that cannabinoid-based formulations are supportive in relief of DM symptoms, Nexien will likely proceed with clinical studies in accordance with U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) protocols.

Earlier this year Nexien filed a utility patent application with the United States Patent and Trademark Office (USPTO) relating to the use of cannabinoids to treat myotonia, myotonic dystrophy, and other related dystrophies. That application is based on a previously-filed provisional patent application that was filed by the Company in 2017.

Alex Wasyl, Chief Executive Officer stated, “There is significant anecdotal evidence reinforced by the patient questionnaire results that the use of cannabinoids provides relief to many  myotonia and myotonic dystrophy patients. This evidence resulted in our engagement of Dr. Schoser as a Nexien advisor in July. We are hopeful that Dr. Schoser´s summary of clinical observations in Germany will help support our work regarding the use of cannabinoid-based formulations for these diseases, and will enable Nexien to proceed with pre-clinical and clinical studies under FDA protocols.”

About Myotonia and Myotonic Dystrophies

Myotonia refers to a neuromuscular condition in which the relaxation of a muscle is impaired, and can affect any muscle group of the body. Because a repeated effort is required to relax the muscle, individuals with myotonia may have significant trouble with normal daily activities, including releasing their grip on objects (i.e. knife, fork and spoon), and having difficulty rising from a seated position, or beginning to walk. Patients suffering from myotonia often walk with a stiff, slow, and awkward gait.

DM is an autosomal dominant transmitted genetic disorder can affect all parts of the human body, but predominantly affects muscular function. Symptoms include gradually increased muscle loss and weakness. There is currently no cure for DM and various drugs are often prescribed to manage symptoms without great success.

About Dr. Benedikt Schoser

Dr. Benedikt Schoser is the senior consultant neurologist and co-chair of the Friedrich-Baur Institute, Germany’s major national referral center for rare neuromuscular diseases. His clinical and research interests are in the field of multisystemic neuromuscular diseases, and metabolic and myotonic myopathies.

Dr. Schoser is an Associate Professor of Neurology at the Ludwig Maximilians University in Munich, Germany. Since 2010 he has also been the head of the Interdisciplinary Center for Neuromuscular Disorders at the University’s Munich campus. Dr. Schoser has authored and co-authored more than 200 articles in peer-reviewed journals and has contributed more than 20 chapters to books on neurology and muscle pathology.

About Nexien BioPharma Inc.

Nexien BioPharma is a US-based pharmaceutical company engaged in the formulation, development and commercialization of cannabinoid-based pharmaceuticals in accordance with U.S. Food and Drug Administration (“FDA”) pre-clinical and clinical pathways, to address a broad range of medical conditions and disorders.

Nexien BioPharma website: www.NEXIENBioPharma.com

Nexien Disclosure Notice: This press release may contain “forward-looking statements, which are deemed to be any statements made by or on behalf of Nexien BioPharma that are not statements of historical facts. These statements reflect current beliefs, and a number of important factors could cause actual results to differ materially from those expressed in this release, including the factors set forth in “Risk Factors” in our most recent Form 10-K filed with the Securities and Exchange Commission (SEC) and subsequent filings with the SEC.  Readers are cautioned not to place reliance on these forward-looking statements, which are valid only as of the date they were made. Nexien BioPharma undertakes no obligation to update or revise any forward-looking statements to reflect new information or the occurrence of unanticipated events or otherwise, except as expressly required by law.

 

Company Contact:

         Mark Lubchenco

Director of Investor Relations

Nexien BioPharma Inc.

Tel. 1-303-495-7583

Email:mlubchenco@nexienbiopharma.com

 

 


StaffStaffNovember 2, 2018
img_mjlink.jpg

5min610

Expanding its member base and market share in the rapidly growing global cannabis industry.

DENVER, CO – November 2, 2018 /AxisWire/ MjLink.com, Inc., a wholly owned subsidiary of Social Life Network, Inc. (OTCQB: WDLF), announced today that the company has a total of 1.3 million registered users on both MjLink.com (their B2B social network) and WeedLife.com (their C2C social network). The company enables business professionals and consumers to connect, share and grow their industry knowledge and brand awareness through the most active online cannabis community in the world.In addition to breaking through the one-million-member milestone, for the first time since the cannabis social networks launch in 2013, they have surpassed 50 million monthly page views.

In an 8-K that Social Life Network submitted on September 25th, 2018, the Company announced the incorporation of MjLink.com, Inc., a wholly owned subsidiary that is planning an IPO on a Canadian exchange in 2019.Executive management has now targeted a minimum of $5M USD to be raised for that IPO, at a valuation of $35 million for MjLink.com, Inc.

“MjLink and WeedLife registering a combined 1.3 million members on our network, and exceeding 52 million monthly page views in October, is a very significant milestone for us,” says CEO, Ken Tapp. “More importantly is the number of monthly active user sessions and the amount of time they spend on our networks each month.This past month we saw 2.6 million user sessions of which 367 thousand were active registered members. By using the latest data from Statista.com that values social network active users at $97 a year for advertising consumption, we’ve arrived at a much more realistic value of $35M USD for MjLink, versus using our 1.3 million registered users to value the company, given not all of them are active users each month”, added Tapp.

Mark DiSiena, CFO of Social Life Network, noted that “We are only comfortable coming up with our social networks value based on real user traffic as of today, and not the unrealized user traffic a few years from now that many of the social networking companies prefer using when coming up with a pre-IPO valuation.”

About Social Life Network, Inc.

Social Life Network, Inc. is an artificial intelligence and blockchain powered social network and e-commerce technology company based in Denver Colorado. They launched their first social network, WeedLife.com, in the cannabis and hemp industry in 2013, and have since launched niche e-commerce social networks to meet the growing demand for social technology in the residential Real Estate industry and many sports verticals including Golf, Cycling, Tennis, Soccer, Hunting & Fishing world-wide.
For more information, visit https://www.SocialNetwork.ai

Disclaimer

This news release may include forward-looking statements within the meaning of Section 27A of the United States Securities Act of 1933, as amended, and Section 21E of the United States Securities and Exchange Act of 1934, as amended, with respect to achieving corporate objectives, developing additional project interests, the Company’s analysis of opportunities in the acquisition and development of various project interests and certain other matters. No information in this press release should be construed as any indication whatsoever of the Company’s or MjLink’s future financial results, revenues or stock price. There are no assurances that the Company will successfully take MjLink public in Canada. These statements are made under the “Safe Harbor” provisions of the United States Private Securities Litigation Reform Act of 1995 and involve risks and uncertainties which could cause actual results to differ materially from those in the forward-looking statements contained herein.

Contact:

Investor Relations
IR@Social-Life-Network.com
855-933-3277


StaffStaffNovember 2, 2018
cheeringpeople.jpg

4min1120

There is unprecedented support for marijuana legalization, and advocates say the midterm elections could mark the point of no return for a movement that has been gathering momentum for years. You can find the latest information on legislative efforts here at the Green Market Report in our Bill Track tab.

Political oddsmakers at MyBookie.ag agree. Currently, the online betting site favors pro-marijuana initiatives to pass in several states on the November ballot, including ultra-conservative Utah.

Many are calling these elections the “tipping point” for cannabis, with 4 states going to vote on major cannabis laws, and cannabis measures showing up on local ballots across states. As an example, California itself, which legalized cannabis recreationally earlier this year, will still have 82 ballot measures across the state related to cannabis.

If voters in all four states approve, 2018 will conclude with 32 medical marijuana states and 11 that allow recreational cannabis for adults. This would add even more to the movement for national reform, applying significant pressure for the repeal of federal prohibition.

These elections are pretty monumental, actually, because for the first time Millennials will surpass Baby Boomers as the largest generation eligible to vote. There are 8 million more voters eligible in the USA to vote now than there were when President Donald Trump was elected to office. Young voters are said to be what can tip the election, as long as they get to the ballot box.

It’s been just six years since Colorado and Washington became the first states to legalize marijuana, but in that short time, seven other states and the District of Columbia have followed. On top of that, the entire country of Canada legalized use last week.

Below are odds for each state with initiatives on the November ballot courtesy of MyBookie.ag.

Adult Use:

Will Michigan legalize recreational Marijuana before 2020?

Yes       1/2 (-200)

No        8/5 (+160)

Will North Dakota legalize recreational Marijuana before 2020?

Yes       1/4 (-400)

No        3/1 (+300)

Medical:

Will Missouri remove restrictions on medical marijuana before 2020?

Yes       1/2 (-200)

No        8/5 (+160)

Will Utah remove restrictions on medical marijuana before 2020?

Yes       4/6 (-150)

No        11/10 (+110)

 

Betting Glossary: Favorites (likely winners) have the minus (-) number which correlates to payout. For example, -200 means you’d need to wager $200 to win $100. Conversely, plus (+) numbers are for underdog bets and have higher payouts because they are less likely to happen, +160 means you’d win $160 with a $100 wager.


StaffStaffNovember 1, 2018
img_mgo-ello.jpg

6min610

Alliance to Offer New Collaborative Big-4 Quality Accounting Service Offerings Across their Cannabis Practice

LOS ANGELES–OCTOBER 31, 2018/AxisWire/ MGO LLP, one of the fastest growing CPA and Financial Advisory Services firm in the nation, and partner firm ELLO LLC, a leader in the cannabis financial, tax and broader advisory services space, announced their official alliance entailing an exclusive collaborative professional services offering across their rapidly growing cannabis practices in the U.S. and Canada.

“As the cannabis industry continues to experience massive growth, inevitable financial and operational challenges will develop and the MGO-ELLO alliance is uniquely positioned to provide the highest quality consulting and professional services needed.  The cannabis industry has long lacked access to world-class accounting, tax, audit and advisory services – that changes as of today,” said Evan Eneman, ELLO CEO. “In an effort to help clients better prepare for and meet forthcoming business obstacles, we’ve created a collaborative service offering through the MGO and ELLO alliance that will instill transparency, responsibility and legitimacy with operational best practices that will serve as an integral resource for our clients.”

The alliance of MGO and ELLO grants clients access to a more robust advisory team empowering them to better navigate the complex dynamics in current emerging cannabis markets. This full suite of financial services includes mergers and acquisitions support, capital raising activities, due diligence, regulatory compliance, finance effectiveness, performance reviews, operations improvements, strategy consulting, as well as tax services, outsourcing services and more. To support the continued growth of the industry, the alliance has also solidified a deeper strategic partnership with leading Canadian chartered accountancy and business advisory firm MNP LLP.

“MGO-ELLO now provides advisory services for a large and increasing number of capital market activities, such as Canadian IPOs, RTOs and M&A transactions. As the industry as a whole begins to flourish, we are starting to witness an influx of cannabis companies seeking capital to achieve their business goals. In anticipation of this increased capital demand, our cannabis practice is poised to become the go-to partner for cannabis companies to best leverage these complex transactions,” said Scott Hammon, Assurance Partner and Cannabis Practice COO. “Our alliance with MNP allows us to provide advanced advisory services that will further enhance our ability to help our cannabis clients maintain legitimacy and profitability in today’s emerging landscape.”

To meet with the MGO | ELLO team and inquire about their services to the industry, please visit the team in Las Vegas at the Marijuana Business Conference from November 14-16 at booth #1827, “Going Public in Canada, Eh!”. In addition to the MGO | ELLO alliance and MNP LLP, booth partners include Aird & Berlis, Haywood Securities and the Canadian Securities Exchange.

To learn more about the MGO | ELLO Alliance’s award-winning accounting, consulting, and staffing services to the cannabis industry visit www.mgocpa.comand www.elloinsights.com.

About MGO

One of the fastest growing professional services firms in the US, MGO combines deep industry expertise with proven accounting and advisory solutions to deliver tangible results. MGO is ranked as one of the top CPA firms in the nation, with clients ranging from global aerospace and technology leaders to innovative start-ups and not-for-profit organizations – from the largest government entities in the country to the biggest names in entertainment. For more information, please visit www.mgocpa.com.

About ELLO

ELLO is the leading professional services firm within the cannabis industry. Our mission is to help shape the business environment and regulatory landscape for the cannabis industry and develop and implement best practices for cannabis operators.We have worked with over 400 businesses to help them solve complex problems across a range of areas including regulatory compliance, capital markets advisory, tax services, operational improvements as well as staffing needs. Our team’s unique and innovative approach helps ensure our clients are able to grow and scale their businesses in an industry that is constantly changing.  ELLO is an MGO member firm. For more information, please visit elloinsights.com.

Media Contacts
Cynthia Salarizadeh / Christina Panta
KCSA Strategic Communications
212.682.6300 / 212.896.1208
cynthia@kcsa.com / cpanta@kcsa.com

 



About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 2 hours

$ACRG Acreage Holdings Begins Trading On CSE

@GreenMarketRpt – 19 hours

AxisWire Hosts First Annual STAR Media Awards

@GreenMarketRpt – 2 days

$TLRY Reports $10 Million In Revenue As Prices For Cannabis Fall

Back to Top

You have Successfully Subscribed!